Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT05581719 |
| Title | A Phase 1/2a Study Evaluating Allocetra-OTS as Monotherapy or in Combination With Anti-PD-1 Therapy for the Treatment of Advanced Solid Tumor Malignancy |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Enlivex Therapeutics RDO Ltd. |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | ESP |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Rambam Medical Center | Haifa | Israel | Details | |||
| Hadassah Medical Center | Jerusalem | Israel | Details | |||
| Sheba Medical Center | Ramat Gan | Israel | Details | |||
| Sourasky Medical Center | Tel Aviv | Israel | Details | |||
| Clínica Universidad de Navarra | Madrid | Spain | Details | |||
| NEXT Madrid | Madrid | Spain | Details |